
Integrity Concerns in Ticagrelor Trials Challenge Clinical Confidence
New scrutiny has emerged over the trial data supporting ticagrelor (Brilinta; AstraZeneca), after a BMJ investigation revealed inaccuracies in 2 foundational studies that assessed platelet inhibition efficacy. These trials were critical in establishing the …